2009
DOI: 10.1016/j.tube.2008.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
54
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 51 publications
(58 citation statements)
references
References 46 publications
4
54
0
Order By: Relevance
“…Many studies have now focused on other cytokines, in addition to IFN-␥, in the search for protective host factors (21,23,24).…”
Section: Discussionmentioning
confidence: 99%
“…Many studies have now focused on other cytokines, in addition to IFN-␥, in the search for protective host factors (21,23,24).…”
Section: Discussionmentioning
confidence: 99%
“…There was no statistically significant difference in the distribution of MCP1 genotypes between HD patients without CVD and healthy controls. 7 In the study by Park et al 15 on Korean subjects, the promoter polymorphism of MCP1 (MCP1 -2518G>A) was involved in HBV clearance, which is associated with the development of antibodies to surface antigen of HBV (anti-HBs): the frequency of homozygotes for the MCP1 -2518A allele among chronic HBV carriers was significantly higher than that among spontaneously recovered subjects. However, a year later, Cheong et al 16 did not demonstrate an association of MCP1 -2518G>A with the outcome of HBV infection in Korean patients.…”
mentioning
confidence: 99%
“…However, in vivo evidence suggests some protective role for iNOS in human tuberculosis (TB). Genome-wide association studies link NOS2 with an increased incidence of TB (4)(5)(6)(7)(8), although the expression and/or activity of iNOS resulting from these polymorphisms are unknown. Still other investigators reported that iNOS and NO production in TB patients correlates with less severe disease, and NO production by human alveolar MFs ex vivo inhibits mycobacterial growth (9)(10)(11)(12)(13)(14)(15).…”
mentioning
confidence: 99%